Zeer Oxford Nanopore Technologies / intent / oxford-nanopore-technologies

Oxford Nanopore Technologies

1001-5000 employees·Oxford, United Kingdom·nanoporetech.com

Observed, not inferred · updated weekly

Buying intent

91 tracked signals | Top 15 topics are below | Sales and Engineering are carrying most of it.

53signals · 30 days
53topics tracked
13.16%attributed to a team

Attention by team

LinkedIn activity, by team

Where Oxford Nanopore Technologies's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Precision Medicine
Public Health
Bioinformatics
Next Generation Sequencing
Hiring
Sales
Sales to Artificial Intelligence: no signal
Low25% of team Sales to Precision Medicine: Low, 25% of this team's signals
Low25% of team Sales to Public Health: Low, 25% of this team's signals
Low25% of team Sales to Bioinformatics: Low, 25% of this team's signals
Sales to Next Generation Sequencing: no signal
Low25% of team Sales to Hiring: Low, 25% of this team's signals
Engineering
Engineering to Artificial Intelligence: no signal
Engineering to Precision Medicine: no signal
Engineering to Public Health: no signal
Engineering to Bioinformatics: no signal
Engineering to Next Generation Sequencing: no signal
Low100% of team Engineering to Hiring: Low, 100% of this team's signals
Others
High61% of team Others to Artificial Intelligence: High, 61% of this team's signals
Low12% of team Others to Precision Medicine: Low, 12% of this team's signals
Low9% of team Others to Public Health: Low, 9% of this team's signals
Low6% of team Others to Bioinformatics: Low, 6% of this team's signals
Low9% of team Others to Next Generation Sequencing: Low, 9% of this team's signals
Low3% of team Others to Hiring: Low, 3% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
96%
last
11d ago
Precision Medicine
LinkedIn
Low volume
94%
last
5d ago
Public Health
LinkedIn
Low volume
98%
last
12d ago
Bioinformatics
LinkedIn
Low volume
92%
last
18d ago
Next Generation Sequencing
LinkedIn
Low volume
87%
last
5d ago
Hiring
LinkedIn
Low volume
96%
last
11d ago
BioTechnology -> Microbiology
LinkedIn
Low volume
98%
last
13d ago
Molecular Biology
LinkedIn
Low volume
98%
last
12d ago
AI Transformation
LinkedIn
Low volume
98%
last
19d ago
Pharmaceutical
LinkedIn
Low volume
98%
last
19d ago
Talent Acquisition
LinkedIn
Low volume
95%
last
19d ago
Agentic AI System
LinkedIn
Low volume
98%
last
18d ago
QR Code
LinkedIn
Low volume
96%
last
20d ago
Food Safety
LinkedIn
Low volume
96%
last
26d ago
Business Outcomes
LinkedIn
Low volume
98%
last
22d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Oxford Nanopore Technologies

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others15 active
Directorresearching Artificial Intelligence
in
researching Public Health
in
researching Molecular Biology
in
researching Pharmaceutical
in
researching Customer Engagement
in
Senior ICresearching Public Health
in
Senior ICresearching Next Generation Sequencing
in
researching Human Resources -> Employee Services
in
Directorresearching Precision Medicine
in
Chief Scientific Officer
Executiveresearching Artificial Intelligence
in
strategic biopharma development manager
researching Antibody discovery
in
Vice President of Strategic Planning
VPresearching Career Development
in
Associate Director, Procurement Wafer to Chip
Directorresearching Medical Technology
in
Regional Talent Acquisition
researching Railway transport
in
+ 5 more in Others
Sales6 active
Field Application Scientist
researching BioTechnology -> Microbiology
in
VP Sales, EMEAI
researching Hiring
in
field application scientist
researching Bioinformatics
in
account executive
researching QR Code
in
senior account manager netherlands
researching Clinical Specialist
in
Vice President, Commercial EMEAI
VPresearching Precision Medicine
in
+ 6 more in Sales
Engineering1 active
production engineer
researching Hiring
in
+ 1 more in Engineering
Marketing1 active
Chief Product and Marketing Officer
Executiveresearching Shelf Life
in
+ 1 more in Marketing
Operations1 active
Director, Commercial Operations, Americas
researching Dreamforce
in
+ 1 more in Operations

See everyone, not just the first 10

24 people across every department at Oxford Nanopore Technologies, plus a LinkedIn profile link for each.

Primary products / business lines

LinkedIn company profile

Oxford Nanopore Technologies plc was founded in 2005 as a spin-out from the University of Oxford. The company now employs more than 1000 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Francis Van Parys, has a track record of delivering dis

New capability sought

Employee posts (LinkedIn)

Public Health; BioTechnology -> Microbiology; Molecular Biology; Pharmaceutical

Top accounts researching Oxford Nanopore Technologies

names withheld on the public page

These are companies whose own people brought up Oxford Nanopore Technologies unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

151,426 companies · 839,012 people are researching Artificial Intelligence

Oxford Nanopore Technologies's own team shows 20 signals on this topic. No one outside Oxford Nanopore Technologies has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Precision Medicine1,307 cos · 4,297 people
  • Public Health6,422 cos · 29,917 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Oxford Nanopore Technologies.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 4 people; Leadership — 2 people; Marketing — 1 person; Operations — 1 person; HR / Talent — 1 person; Engineering — 1 person

What's been said

public posts mentioning Oxford Nanopore Technologies

Up to 9 public excerpts naming Oxford Nanopore Technologies from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

London Calling Studio Avengers Assemble! This year at London Calling, we will be hosting a series of interviews for the thousands of you who tune in online! Thomas Bray Gretchen Weightman Chris Swagell Kim Ferguson and I will welcome speakers and attendees from the conference to talk about the bigger picture. What are the barriers to clinical adoption in genomics? How does cross continental collaboration make better science? Let us know any questions you would like discussed in the studio! Oxford Nanopore Technologies

May 2026
LinkedIn

I’m incredibly proud and excited to support the DecodeME project and the important work being done to advance research into ME/CFS and Long Covid, alongside Action for ME , EMBL and The University of Edinburgh . These conditions have a profound impact on millions of people worldwide, yet research into their underlying causes has historically been underfunded and underrepresented. So much so that ME was only recently acknowledged as a health condition. That’s why it’s so encouraging to see DecodeME secure new funding to continue this vital work. By contributing to one of the largest disease specific whole-genome sequencing datasets, with thousands of genomes being analysed, the project has the potential to uncover the genetic drivers behind these complex diseases. The ultimate goal is clear: to build a better understanding of ME/CFS and Long Covid, paving the way for improved diagnosis, better care, and more targeted treatments for patients. It has been inspiring to be part of a project helping to drive meaningful progress in an area where so many people have waited far too long for answers. The collective team working behind the scene with dedication to make a change are superhuman in my book and motivate Oxford Nanopore Technologies to do more everyday! Chris Ponting , Sonya Chowdhury , Olivia Elliot , Ashley E. , to name just a few. Nirmala Santiapillai Rachel Hipkin #DecodeME #MECFS #LongCovid #Genomics #Research

May 2026
LinkedIn

Absolutely brilliant that this study is going ahead. Like many people, I have many friends affected by conditions that cause chronic exhaustion. Which is worse - the affects on those lives, or the way society can sometimes respond to a condition whose causes are so hard to characterise? Looking forward to seeing more light shed on the causes, through the lens of information rich genomics 💪 Oxford Nanopore Technologies Action for ME EMBL The University of Edinburgh Tonya McSherry Nirmala Santiapillai

May 2026
LinkedIn

Reposting this amazing experience with a truly outstanding team 🧬✨ Oxford nanopore technologies is becoming an essential part of every modern genomics lab. With ONT, we are moving toward a future where nothing remains undiagnosed and where new discoveries become possible every day. 🚀 To this incredible group: your harmony, engagement, curiosity, and passion made this one of the most memorable trainings I’ve ever delivered. Every one of you was unique, and I’m already looking forward to your future publications and discoveries using ONT. The future is yours 🌟 Oxford Nanopore Technologies #OxfordNanopore #NanoporeSequencing #Genomics #LongReadSequencing #PrecisionMedicine #DNASequencing #BiomedicalResearch #ClinicalGenomics #MolecularBiology #PromethION2i #HealthcareInnovation #ScientificResearch #Bioinformatics #GenomicMedicine #ONT #FutureOfMedicine #LifeSciences #ResearchInnovation #ScienceCommunity #NextGenerationSequencing

May 2026

About this data. Oxford Nanopore Technologies (nanoporetech.com). Department attribution is 13.16%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries